These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11746271)

  • 21. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma.
    Meazza R; Basso S; Gaggero A; Detotero D; Trentin L; Pereno R; Azzarone B; Ferrini S
    Int J Cancer; 1998 Oct; 78(2):189-95. PubMed ID: 9754651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Liu Y; Zhao X; Sun X; Li Y; Wang Z; Jiang J; Han H; Shen W; Corrigan CJ; Sun Y
    Prostate; 2015 Dec; 75(16):1844-56. PubMed ID: 26356122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
    Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
    Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer.
    Ponomareva L; Liu H; Duan X; Dickerson E; Shen H; Panchanathan R; Choubey D
    Mol Cancer Res; 2013 Oct; 11(10):1193-202. PubMed ID: 23864729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance.
    Albrecht M; Renneberg H; Wennemuth G; Möschler O; Janssen M; Aumüller G; Konrad L
    Histochem Cell Biol; 1999 Jul; 112(1):51-61. PubMed ID: 10461812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.
    Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
    Int J Oncol; 1998 Nov; 13(5):927-34. PubMed ID: 9772281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
    Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
    Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.